$HHSE NEWS: MINUTES OF THE BOARD OF DIRECTORS MEETING –

New Post Public Reply Private Reply Replies (0) Message Board
HHSErocks Infinitehealthwealth #101410
113
$HHSE NEWS: MINUTES OF THE BOARD OF DIRECTORS MEETING – June 11, 2024

https://www.otcmarkets.com/otcapi/company/fin...67/content

HANNOVER HOUSE, INC.



1722 N. College Ave. C303, Fayetteville, AR 72703

MINUTES OF THE BOARD OF DIRECTORS MEETING – June 11, 2024



A special meeting of the Board of Directors of Hannover House, Inc. was held on

Tuesday, June 11, 2024 telephonically at 1:30-pm CST. The purpose of this meeting was

to approve certain distribution and financing commitments on behalf of new, feature

film productions being developed by Company and others, as were initiated at the

Cannes, 2024 Film Festival and Marche du Filme. The following items describe the

issues addressed, and where indicated, the actions taken by the Board.


1). TWO MAJOR PRODUCTIONS WITH FORMA FILMZ / HUNGARIAN PARTNERS –

Regarding the film incentives, equity funding and studio co-production opportunities in

Hungary, the Board reviewed the terms of the ventures covering two major feature

productions, each with top commercial stars. Subject to Company’s final approval of the

casting, key personnel, production plans and budgets, the Board approved the issuance

of “soft” distribution guarantees from the Company (e.g., non-recourse commitments”

covering distribution of the films in North America, and / or the sublicensing of said

films to a major studio partner.)



2). ONE MAJOR PRODUCTION WITH TEMPUS PRODUCTIONS – Regarding the epic

action-adventure feature, “TEMPUS PORTA” – featuring three major stars – the Board

reviewed the terms of the production financing arrangements and the benefits to

Hannover House. ventures covering this Malta-based feature production. Subject to

Company’s final approval of the principal casting, key personnel, production plan and

budget, the Board approved the issuance of a “soft” distribution guarantee from the

Company (e.g., a non-recourse commitment” covering distribution of the film in North

America, and / or the sublicensing of said films to a major studio partner).



3). “INDIGENOUS” AND “FADE-‘EM’UP” PRODUCTIONS – Regarding these two USA

based, lower budgeted feature productions, the Board reviewed the production plans

and required financing shortfalls required. The Board agreed to include both

productions into the “use of proceeds” submission for a newly structured, five-million

dollar (USD $5,000,000) off-balance-sheet production equity funding arrangement with

a New York-based private equity fund. As the detailed terms of this new funding venture

are still under negotiation, the Board authorized communications with the production

entities of these two films, with the expression of the Company’s “interest” and “effort” - subject to the closing of the production equity funding venture.

There being no further issues addressed at this meeting, the Board adjourned at 2:25

pm.



SIGNATURES



Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has

duly caused this report on the Minutes of the Board of Directors Meeting of Hannover

House, Inc. to be signed on its behalf by the undersigned hereunto duly authorized.



HANNOVER HOUSE, INC.

(Registrant)

Date: June 12, 2024

/s/ Eric F. Parkinson

By: ERIC F. PARKINSON

Chairman, C.E.O., President & Secretary
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sarepta Under Scrutiny: KSF's Investigation Deepens

Updated Category News Views 3

A Troubling Chapter for Sarepta Therapeutics It's not every day that a company's dirty laundry gets hung out for all to see, especially when we're talking about Sarepta Therapeutics, a player in the rare disease treatment space. But that's exactly where we find ourselves this fine day—a bit like kicking a hornet's nest, if you ask me. Led by the former Louisiana...

Continue Reading
Cyngn: A Deep Dive into Its Robust 24-Patent Portfolio

Updated Category News Views 4

Cyngn's Growing Patent Portfolio: A Robust Defense Ah, Cyngn Inc., the hotshot in AI-powered autonomous vehicle tech, is flexing its muscles with a solid 24-patent stash. We're talking about a company that's not messing around, racking these up since they decided to dive head-first into solving the brain-busting problems of the industrial sector. Their strategy? Build and...

Continue Reading
New Concierge Pediatric Care at Weill Cornell Launches

Updated Category News Views 3

A New Way Forward in Pediatric Care When a couple of seasoned pediatricians decide it's time for something fresh, eyes and ears perk up. Enter Dr. Paul W. Chung and Dr. Jane E. Rosini, diving headfirst into a revolutionary pediatric concierge program courtesy of Concierge Choice Physicians (CCP). We're talking a substantial shake-up at Weill Cornell Medicine, aiming to...

Continue Reading
Postal Service Defends New Rule Amid Speculation

Updated Category News Views 3

USPS Navigates Election Mail Controversies The U.S. Postal Service has found itself in the eye of a political storm, thanks to the latest Federal Ballot Mail Rule. Led by Postmaster General David Steiner, the USPS is setting the record straight amidst swirling misinformation and skepticism about its recent actions. This is not just a postal service under scrutiny—it's a...

Continue Reading
Acepodia's ACE723 Clears FDA Hurdle for Hepatocellular Push

Updated Category News Views 6

Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...

Continue Reading
BellRing Brands Faces Legal Probe; Fiduciary Duties Questioned

Updated Category News Views 1

What's Stirring at BellRing Brands? Hey, no time like the present to dive headfirst into this mess BellRing's found itself in. On the heels of a lackluster sales forecast, just announced about a year ago, Kahn Swick & Foti's got their magnifying glasses out, searching for any shady dealings by those running the show at BellRing Brands, LLC. Why Is BellRing in the Hot...

Continue Reading
S&P 500 Shuffle: Bloom, Illumina, Everpure Join Frenzy

Updated Category News Views 5

Index Shuffles Stir Market Pot Changes are afoot, folks, with the movers and shakers of the market indices stepping into the spotlight. A lot is brewing with S&P Dow Jones Indices making significant switches effective September 21, 2026—right before trading heats up. You better believe it's affecting more than a couple of tickers. Who's In and Who's Out? If you’ve...

Continue Reading
TrailBlazer Magazine Snags a Tribune for In-House Design

Updated Category News Views 4

Who Knew? Design Awards Aren't Just for Pretty Pictures TrailBlazer Magazine gets a pat on the back from GDUSA's 2026 Inhouse Design Awards, a nod to top-notch design work. With over 4,000 entries across the board, getting into the top 10 percent is like finding a steakhouse with zero line on a Friday night. Not exactly common, right? Design Worth Cheering For The winning...

Continue Reading
MMRO Achieves URAC AI Accreditation, Ensures Compliance

Updated Category News Views 4

A Milestone in Healthcare AI: MMRO's New Accreditation When AI in healthcare gets an official nod from the big guys like URAC, it's a significant moment. We're talking about Managed Medical Review Organization, Inc. (MMRO), a firm that's just earned the URAC Artificial Intelligence in Health Care Accreditation. Now, this isn't just some rubber stamp; it's a testament to...

Continue Reading
Dimerix Locks Down A$34M Loan: No Shareholder Dilution

Updated Category News Views 2

Dimerix Grabs Non-Dilutive Funds amid Kidney Trials Here we go with Dimerix's latest move, folks. They roped in A$34 million through a cozy get-together with lenders from Australia and the U.S. What's the kicker? This cash won't touch shareholder equity. So, breathe easy, investors. It's a rare feat to pull off non-dilutive funds these days, especially in the biopharma...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming the Narcolepsy Market: Innovations Ahead

Updated Category News Views 166

The Evolving Landscape of the Narcolepsy Market The narcolepsy market is undergoing significant changes as it shifts from merely managing symptoms to developing targeted therapies that tackle the root causes of the disorder. Traditionally, treatments focused on alleviating symptoms, but advancements now emphasize addressing the underlying neurochemical issues, primarily...

Continue Reading
UBS Analysts Share Insights on China Stocks Strategies

Updated Category News Views 242

UBS Analysts Offer Insights on China's Equity Market In a recent discussion, UBS strategists have expressed a level of caution regarding China's equity market as they look into the evolving landscape of 2025. It's noted that local A-share investors appear hesitant to seize buying opportunities, influenced by a myriad of factors that create uncertainty in the market....

Continue Reading
Palisade Bio's Special Meeting Cancellation: What You Need to Know

Updated Category News Views 133

Palisade Bio Cancels Special Meeting of Stockholders Palisade Bio, Inc. (Nasdaq: PALI) is a clinical-stage biopharmaceutical company making strides in developing innovative treatments for autoimmune, inflammatory, and fibrotic diseases. Recently, the company announced an important decision regarding its special meeting of stockholders. The special meeting, originally...

Continue Reading
Vivendi Reports Impressive 4.5% Revenue Growth in 2024

Updated Category News Views 123

Remarkable Revenue Growth for Vivendi Vivendi has announced an impressive increase in its revenues for the first nine months of 2024, emphasizing strong growth across its core business sectors. The company reported a revenue increase of 4.5% at constant currency and perimeter, compared to the same period in the previous year. This growth showcases the resilience and...

Continue Reading
Revolution in Home Renovation Arrives with Spray-Net Franchise

Updated Category News Views 226

Fresh Approach to Home Makeovers Home remodeling isn’t just about slapping on a new coat of paint anymore. In February 2026, Spray-Net is gearing up to launch in Allen, Texas, shaking things up in the renovation game. This venture represents a leap forward—not only for franchise growth but for homeowners who are sick and tired of traditional, drawn-out renovations....

Continue Reading